Furthermore, the epithelial-mesenchymal transition (EMT) markers (N-cadherin, E-cadherin and Vimentin) were also determined and the results showed that overexpressed LncRNA ADAMTS9-AS2 inhibited N-cadherin and Vimentin, while promoted E-cadherin expressions in GC cells, which were all reversed by overexpressing miR-223-3p in GC cells (Figure 3G–3J). The gene discussed is VIM; the disease is gastric cancer.